Aldeyra stock jumps 50 percent after eye allergy trial success
March 26, 2019 at 11:57 AM EDT
Quiet local biotech Aldeyra Therapeutics made some noise Tuesday, reporting that its first treatment for eye allergies succeeded in a late-stage trial.
